Diabetomics Medical Private Limited, a active private limited company, was established on 16 June 2015 in Medak, Telangana, India. Engaging in medical & laboratory equipment within the professional, scientific and technical sector, it holds CIN: U24233TG2015PTC099351. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.01 Cr and a paid-up capital of ₹2.90 M.
It upholds a compliant status. Employing 38 professional, Its leadership includes Anshuman Jaiswal (Director), Koduru Iswara Varaprasad Reddy (Director), Ramadhara Naidu Kancharla (Director). Past directors included Sumeet Roy, Vishnupriyarao Paturi, Bobba Venkatadri. It holds no open charges and ₹5.00 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No 26A And 26B, Muppireddipally,, Medak, Telangana, 502336.
U24233TG2015PTC099351
099351
16 June 2015
₹1.01 Cr
₹2.90 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Diabetomics Medical Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anshuman Jaiswal | Director | 08 May 2024 | Current |
| Koduru Iswara Varaprasad Reddy | Director | 16 Jun 2015 | Current |
| Ramadhara Naidu Kancharla | Director | 08 May 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Director | 28 Dec 2023 | Past |
| Pramod Abcsdd | Nominee Director | 15 Apr 2024 | Past |
| Pramod Abcsdd | Director | 22 Feb 2017 | Past |
| Pramod Abcsdd | Director | 06 Jul 2025 | Past |
| Pramod Abcsdd | Director | 02 Jul 2025 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Diabetomics Medical Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 11.39% increase. The company also saw a substantial fall in profitability, with a 43.28% decrease in profit. The company's net worth dipped by a decrease of 1.09%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Diabetomics Medical had a public holding of 0.10%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹50,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Mar 2017 | Others | ₹5.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Diabetomics Medical has a workforce of 38 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Diabetomics Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diabetomics Medical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Diabetomics Medical Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Anshuman Jaiswal was appointed as a Director was appointed as a Director on 08 May 2024 & has been associated with this company since 1 year 6 months . was completed.
Progress on Ramadhara Naidu Kancharla was appointed as a Director was appointed as a Director on 08 May 2024 & has been associated with this company since 1 year 6 months . was documented.
Progress on A charge registered on 28 Mar 2017 via Charge ID 100112208 with Others was fully satisfied on 23 Apr 2024. was documented.
The activity Diabetomics Medical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100112208 was registered on 28 Mar 2017. was recorded as a recent event.
The CIN of Diabetomics Medical Private Limited is U24233TG2015PTC099351.
Diabetomics Medical Private Limited is headquartered at Plot No 26A And 26B, Muppireddipally,, Medak, Telangana, 502336.
Diabetomics Medical Private Limited was incorporated on 16 June 2015.
The current directors of Diabetomics Medical Private Limited are
The primary industry of Diabetomics Medical Private Limited is Professional, Scientific And Technical.
Diabetomics Medical Private Limited is unlisted.
The authorized capital of Diabetomics Medical Private Limited is ₹1.01 Cr, and the paid-up capital is ₹2.90 M.
The compliance status of Diabetomics Medical Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX